Northern, WI 2/9/12 (StreetBeat) -- Shares of LTS Nutraceuticals, Inc. (OTCBB:LTSN) have been on a sharp slide for the last, but news of entering the U.S. markets with its recently acquired BioCalth product may help slow the roll. The company, a developer and manufacturer of nutritional and personal care products, completed its acquisition of Biocalth International, Inc., Giantceuticals, Inc. and HerbSource Enterprises, Inc. (collectively “Biocalth”), as announced on January 19, 2012.Today, the company said today that it has penetrated the U.S. markets with its BioCalth® product on www.Walmart.com and www.Vitaminshoppe.com. This is not the first products helping LTS Nutra to generate revenue in the States as its brands Celadrin® (a cell membrane lubricant) and fit calorie crystals™ are currently sold in national drug store chains and club stores across North America. Additionally, BioCalth is presently being sold in some of the largest drug store chains in Asia and Europe.
“The bone and joint health supplements market continues to rise due to the growing aging population here in the U.S. and we believe BioCalth is unlike any supplement out there in the marketplace today. We are excited that these retailers also sees the potential of BioCalth in the U.S. market and we look forward to what we believe will be a successful brand for many years to come,” stated Chairman of LTS Nutraceuticals, Ted Farnsworth.
Globally, the bone and joint health market expected to top $9 billion in the next five years, with the United States currently representing the largest market in the world.
Shares of LTSN opened are down tepidly by 1.96% at $0.50 on light volume just after the opening bell.
StreetBeat Disclaimer
No comments:
Post a Comment